(WBBM NEWSRADIO) -- Researchers in Washington State say trials of a possible COVID-19 vaccine have shown promising signs in the early stages, and the next step could be coming to Chicago.
The study being done by the COVID-19 Prevention Network has entered its third phase, passing initial stages focused on safety of participants.
“In Phase 3 studies, we’re still looking at safety,” said Dr. Stephaun Wallace, Director of External Relations. “Safety is always a priority. But we’re also really looking at whether it works.”
The Seattle-based network is now accepting volunteers through its website.
“A person can input their information into a registry that clinical trial sites that are participating in these Phase 3 studies will have access to in order to pull from.”
Wallace said it’s still too early to determine where sites will be across the U.S., but that race is a key factor in the decision-making.
“There’s quite a bit of geographic spread of the clinical trial sites around the country,” he said. “My sense is that in order for us to really move forward and reduce the impact of COVID-19 in communities around the world, we will need an effective vaccine.”